cytarabine and Icterus

cytarabine has been researched along with Icterus in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bansal, P; Dayao, Z; Hu, S; Lynch, D; Rojas Hernandez, CM1
Barjas-Castro, ML; Carvalho, MA; Castro, V; Gilli, SO; Locatelli, MF1
Balcar-Boroń, A; Nowaczyk-Michalak, A; Pilecki, O; Trybuś, L; Wysocki, M1
Antony, J; Bergin, M; Menser, MA; Procopis, PG; Shaw, PJ; Stevens, MM1
Blom, J; Burningham, R; Cuttner, J; Falkson, G; Glidewell, O; Holland, JF; Levy, RN; Moon, JH; Onuma, T; Rosner, F; Silver, RT1

Reviews

1 review(s) available for cytarabine and Icterus

ArticleYear
Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
    Journal of medical case reports, 2016, Dec-20, Volume: 10, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Cisplatin; Cytarabine; Enterococcus faecalis; Etoposide; Fatal Outcome; Fever; Gram-Positive Bacterial Infections; Hodgkin Disease; Humans; Jaundice; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Pancytopenia; Rituximab

2016

Other Studies

4 other study(ies) available for cytarabine and Icterus

ArticleYear
Severe immune haemolysis in a group A recipient of a group O red blood cell unit.
    Transfusion medicine (Oxford, England), 2003, Volume: 13, Issue:4

    Topics: ABO Blood-Group System; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Donors; Blood Group Incompatibility; Cisplatin; Cytarabine; Dexamethasone; Erythrocyte Transfusion; Fever; Hemolysis; Humans; Immunization, Passive; Isoantibodies; Jaundice; Lymphoma, Non-Hodgkin; Male; Oligosaccharides; Oligosaccharides, Branched-Chain; Pain

2003
Jaundice following high--dose arabinoside cytosine in a child with acute myelogenous leukemia.
    Acta haematologica Polonica, 1992, Volume: 23, Issue:3

    Topics: Administration, Oral; Cytarabine; Drug Administration Schedule; Female; Humans; Hyperbilirubinemia; Infant; Jaundice; Leukemia, Myeloid, Acute; Remission Induction; Remission, Spontaneous; Time Factors

1992
Bulbar and pseudobulbar palsy complicating therapy with high-dose cytosine arabinoside in children with leukemia.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:2

    Topics: Adolescent; Bulbar Palsy, Progressive; Cerebellar Ataxia; Child; Cytarabine; Female; Humans; Injections, Intravenous; Jaundice; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Paralysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1991
Treatment of adult leukemia with L-asparaginase (NSC-109229).
    Cancer chemotherapy reports, 1971, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Aged; Allopurinol; Anaphylaxis; Asparaginase; Blood Coagulation Disorders; Cytarabine; Daunorubicin; Drug Hypersensitivity; Female; Fever; Gastrointestinal Hemorrhage; Hallucinations; Humans; Hyperglycemia; Injections, Intravenous; Jaundice; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Liver; Male; Mercaptopurine; Methotrexate; Middle Aged; Oral Hemorrhage; Prednisone; Thioguanine; Uremia; Vincristine; Vomiting

1971